Kari Brown, M.D., is the Chief Medical Officer at Revolo Therapeutics, where she leads the company’s clinical and medical strategy. She is an allergist and immunologist physician with a decade of experience in clinical medicine, drug development, and clinical strategy. Prior to joining Revolo she was vice president of clinical development, therapeutic area head of allergy at Nestlé Health Science and senior medical director at Aimmune Therapeutics, where she was part of the team that developed the first regulatory approved treatment for food allergy. Previously, she trained in pediatrics at Vanderbilt University and at Cincinnati Children’s Hospital in the Division of Allergy and Immunology, where she participated as an investigator in multiple allergy therapeutic trials. She holds a medical degree and maters in clinical research from Emory University.